Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Grimm

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Maryland Nurse|September 1, 1990
Is the nurse practitioner in? A day in the life ofM C Grimm
Gut|October 14, 2004
NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?M C Grimm, P Pavli
Gut|May 5, 2001
Heparin as an anti-inflammatory agent: it's no GAG to forget about chemokinesS J Connor, M C Grimm
Inflammatory Bowel Diseases|January 4, 2013
Chemokines in Inflammatory Bowel Disease Mucosa: Expression of RANTES, Macrophage Inflammatory Protein (MIP)-1α, MIP-1β, and γ-Interferon-Inducible Protein-10 by Macrophages, Lymphocytes, Endothelial Cells, and GranulomasM C Grimm, W F Doe
Internal Medicine Journal|February 14, 2013
Thrombotic thrombocytopenic purpura associated with adalimumab (Humira) treatment in Crohn diseaseB Zbaras, L N Sam, M C Grimm
Clinical and Experimental Immunology|March 27, 2014
T helper type 17 pathway suppression by appendicitis and appendectomy protects against colitisR Cheluvappa, A S Luo, M C Grimm
Immunology Today|June 29, 2000
A homing selection hypothesis for T-cell traffickingM P Davenport, M C Grimm, A R Lloyd
Clinical and Experimental Immunology|June 29, 2011
Protective pathways against colitis mediated by appendicitis and appendectomyR Cheluvappa, A S Luo, C Palmer, et al.
Gut|January 1, 1996
Interleukin 8: cells of origin in inflammatory bowel diseaseM C Grimm, S K Elsbury, P Pavli, et al.
Journal of Leukocyte Biology|June 1, 1996
Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosaM C Grimm, S K Elsbury, P Pavli, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Maryland Nurse|September 1, 1990
Is the nurse practitioner in? A day in the life ofM C Grimm
Gut|October 14, 2004
NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?M C Grimm, P Pavli
Gut|May 5, 2001
Heparin as an anti-inflammatory agent: it's no GAG to forget about chemokinesS J Connor, M C Grimm
Inflammatory Bowel Diseases|January 4, 2013
Chemokines in Inflammatory Bowel Disease Mucosa: Expression of RANTES, Macrophage Inflammatory Protein (MIP)-1α, MIP-1β, and γ-Interferon-Inducible Protein-10 by Macrophages, Lymphocytes, Endothelial Cells, and GranulomasM C Grimm, W F Doe
Internal Medicine Journal|February 14, 2013
Thrombotic thrombocytopenic purpura associated with adalimumab (Humira) treatment in Crohn diseaseB Zbaras, L N Sam, M C Grimm
Clinical and Experimental Immunology|March 27, 2014
T helper type 17 pathway suppression by appendicitis and appendectomy protects against colitisR Cheluvappa, A S Luo, M C Grimm
Immunology Today|June 29, 2000
A homing selection hypothesis for T-cell traffickingM P Davenport, M C Grimm, A R Lloyd
Clinical and Experimental Immunology|June 29, 2011
Protective pathways against colitis mediated by appendicitis and appendectomyR Cheluvappa, A S Luo, C Palmer, et al.
Gut|January 1, 1996
Interleukin 8: cells of origin in inflammatory bowel diseaseM C Grimm, S K Elsbury, P Pavli, et al.
Journal of Leukocyte Biology|June 1, 1996
Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosaM C Grimm, S K Elsbury, P Pavli, et al.
Pageof 3